AVDL
Avadel Pharmaceuticals plc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$21.64
+0.00%Margins
Gross margin
94.5%
EBITDA margin
4.1%
EBIT margin
1.8%
Net margin
-0.1%
FCF margin
14.2%
-0.3%
Return on equity
-0.1%
Return on assets
3.3%
Return on invested capital
1.29x
Asset turnover
$35.6M
Cash from operations
$0.94
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025